EUVIMEDEUVIMED entdecken
MetaanalyseÜbersichtsarbeitOpen Access

The Efficacy of Human Papillomavirus Vaccination as an Adjuvant Therapy in Recurrent Respiratory Papillomatosis

Anusha Ponduri iD, Monica C Azmy, Eden Axler, Juan Lin, Rachel Schwartz iD, Magdalena Chirilă iD, Frederik G Dikkers iD, Christina J Yang iD, Vikas Mehta, Mona Gangar

The Laryngoscope · 2023

DOI: 10.1002/lary.30560 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift The Laryngoscope, 2023. Verfasst von Anusha Ponduri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Albert Einstein College of Medicine, Bronx, New York, USA. Hauptthemen laut MEDLINE: Papillomavirus Vaccines, Papillomavirus Infections, Respiratory Tract Infections. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To characterize the efficacy of human papillomavirus (HPV) vaccination as an adjuvant therapy in recurrent respiratory papillomatosis (RRP). Data Sources PubMed, Embase, Cochrane, Google Scholar, ClinicalTrials.gov , and Web of Science databases were queried for articles published before April 2021. Review Methods All retrieved studies ( n = 870) were independently analyzed by two reviewers according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis (PRISMA) statement using predefined inclusion and exclusion criteria. 13 studies met inclusion criteria. A random‐effects meta‐analysis was performed to study intersurgical interval (ISI) and number of surgical procedures per year before and after vaccination.

Results

The systematic review included 13 studies, comprising 243 patients. All studies utilized the Gardasil® quadrivalent vaccine, and one study (Yiu et al. 2019) utilized both the quadrivalent and Gardasil® 9‐valent vaccines. Our meta‐analysis included 62 patients with ISI data across 4 studies, and 111 patients with data on the number of surgical procedures per month across 7 studies. The mean number of surgical procedures decreased by 4.43 per year after vaccination (95% CI, −7.48 to −1.37). Mean ISI increased after vaccination, with a mean difference of 15.73 months (95% CI, 1.46–29.99). Two studies reported on HPV sero‐conversion, with HPV seropositivity of 100% prior to vaccination and 25.93% after vaccination.

Conclusion

The addition of HPV vaccination was associated with an increase in time between surgeries and reduction in the number of surgical procedures required. HPV vaccination may be a beneficial adjuvant treatment for RRP. Level of Evidence NA Laryngoscope , 133:2046–2054, 2023

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus VaccinesPapillomavirus InfectionsRespiratory Tract InfectionsHumansHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18Human Papillomavirus VirusesVaccination

Stichwörter der Autor:innen

human papillomavirus recombinant vaccine quadrivalentlaryngeal papillomapapillomavirus vaccinesrecurrentrecurrent respiratory papillomatosisrespiratory papillomatosistypes 6, 11, 16, 18

Substanzen

Papillomavirus VaccinesHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18

Autor:innen und Institutionen

  • Albert Einstein College of Medicine, Bronx, New York, USA.
  • Department of Otorhinolaryngology - Head and Neck Surgery, Montefiore Medical Center, Bronx, New York, United States.
  • Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Department of Otorhinolaryngology/Head and Neck Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands.

ORCID-Profile: Anusha Ponduri, Rachel Schwartz, Magdalena Chirilă, Frederik G Dikkers, Christina J Yang

Förderung

  • NCATS NIH HHS

Zitieren

APA

Ponduri, A., Azmy, M. C., Axler, E., Lin, J., Schwartz, R., Chirilă, M., Dikkers, F. G., Yang, C. J., Mehta, V., & Gangar, M. (2023). The Efficacy of Human Papillomavirus Vaccination as an Adjuvant Therapy in Recurrent Respiratory Papillomatosis. The Laryngoscope. https://doi.org/10.1002/lary.30560

Vancouver

Ponduri A, Azmy MC, Axler E, Lin J, Schwartz R, Chirilă M, et al. The Efficacy of Human Papillomavirus Vaccination as an Adjuvant Therapy in Recurrent Respiratory Papillomatosis. The Laryngoscope. 2023. doi:10.1002/lary.30560

BibTeX
@article{Ponduri2023,
  author = {Ponduri, Anusha and Azmy, Monica C and Axler, Eden and Lin, Juan and Schwartz, Rachel and Chirilă, Magdalena and Dikkers, Frederik G and Yang, Christina J and Mehta, Vikas and Gangar, Mona},
  title = {The Efficacy of Human Papillomavirus Vaccination as an Adjuvant Therapy in Recurrent Respiratory Papillomatosis},
  journal = {The Laryngoscope},
  year = {2023},
  doi = {10.1002/lary.30560}
}
Kostenlos starten →